In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers
PLOS One · 06.05.2026 · 21 (5) · e0348369
DOI: 10.1371/journal.pone.0348369 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 06.05.2026. Verfasst von Courage Siame und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana. Hauptthemen laut MEDLINE: Garlic, Breast Neoplasms, Biomarkers, Tumor, Sulfur Compounds. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer is the leading cause of cancer mortality among women globally, and drug resistance complicates treatment. Garlic-derived organosulfur compounds exhibit anticancer potential, but their multi-target activity against key breast cancer biomarkers remains unclear. This study utilized AutoDock Vina for molecular docking, OpenBabel for post-docking energy minimization, and employs SWISS-ADME and PreADMET platforms for ADMET profiling to assess six garlic compounds (Z-ajoene, allyl-methyl trisulfide, diallyl disulfide, diallyl sulfide, diallyl trisulfide, and S-allyl-L-cysteine) against clinically relevant breast cancer targets. Z-ajoene showed strong binding to Bcl-2, Topoisomerase II, and CDK-2, while S-allyl-L-cysteine targets five biomarkers. All compounds complied with Lipinski’s rule of five, indicating good oral bioavailability, and display favorable ADMET properties with no mutagenic or tumorigenic risks. Most compounds were predicted to inhibit P-glycoprotein, while only Z-ajoene showed potential inhibition of CYP2C9, suggesting possible drug-drug interactions. Despite moderate affinities, these compounds may serve as potential promising multi-target agents in breast cancer therapy. Our computational findings provide preliminary evidence that garlic-derived compounds warrant further in vitro and in vivo evaluation, particularly in the context of drug-resistant breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
- Medical College of Georgia, The Graduate School, Augusta University, Augusta, Georgia, United States of America.
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.
- West African Genetic Medicine Centre, University of Ghana, Accra, Ghana.
- Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
ORCID-Profile: Courage Siame, Benedict Ofori, Kwabena Owusu Danquah
Zitieren
APA
Siame, C., Ofori, B., Paemka, L., & Danquah, K. O. (2026). In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers. PLOS One, 21(5), e0348369. https://doi.org/10.1371/journal.pone.0348369
Vancouver
Siame C, Ofori B, Paemka L, Danquah KO. In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers. PLOS One. 2026;21(5):e0348369. doi:10.1371/journal.pone.0348369
BibTeX
@article{Siame2026,
author = {Siame, Courage and Ofori, Benedict and Paemka, Lily and Danquah, Kwabena Owusu},
title = {In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348369},
doi = {10.1371/journal.pone.0348369}
}
EUVIMED